To hear about similar clinical trials, please enter your email below
Trial Title:
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT ID:
NCT05810324
Condition:
Cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Diagnostic
Masking:
None (Open Label)
Intervention:
Intervention type:
Drug
Intervention name:
18F-FAPI
Description:
Each patient receive a single intravenous injection of 18F-FAPI, and undergo PET/CT scan
within specified time.
Arm group label:
18F-FAPI
Other name:
FAPI
Summary:
To evaluate the potential usefulness of 18F-FAPI positron emission tomography/computed
tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types
of cancer.
Detailed description:
Subjects with various types of cancer underwent 18F-FAPI PET/CT either for an initial
assessment or for recurrence detection. Tumor uptake was quantified by the maximum
standard uptake value (SUVmax). Using histopathology and follow-up as gold standard, the
sensitivity, specificity, positive predictive value (PPV), negative predictive value
(NPV) and accuracy of 18F-FAPI PET/CT were calculated.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- patients with suspected or new diagnosed or previously treated malignant tumors
(supporting evidence may include MRI, CT, tumor markers and pathology report);
- patients who had scheduled 18F-FAPI PET/CT scan; (iv)
- patients who were able to provide informed consent (signed by participant, parent or
legal representative) and assent according to the guidelines of the Clinical
Research Ethics Committee.
Exclusion Criteria:
- patients with non-malignant lesions;
- patients with pregnancy;
- the inability or unwillingness of the research participant, parent or legal
representative to provide written informed consent.
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
China-Japan Union Hospital
Address:
City:
Chang chun
Zip:
130031
Country:
China
Status:
Recruiting
Contact:
Last name:
Jun Wei
Phone:
+8684995117
Email:
Weijunsy1949@163.com
Start date:
July 1, 2022
Completion date:
January 1, 2025
Lead sponsor:
Agency:
Jilin University
Agency class:
Other
Source:
Jilin University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05810324
